Prediction of novel treatment options for venetoclax-resistant AML cells based on drug repurposing.

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	LADUNGOVÁ Adriana BUŠA Daniel LODHI Yusuf HÝL Jan ČULEN Martin ŠMÍDA Michal
Year of publication	2022
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation